Lifecore Intergel Approvable Despite FDA Objections, MDDR Panel Says
This article was originally published in The Gray Sheet
Executive Summary
Lifecore Biomedical's Gynecare Intergel adhesion prevention solution appears closer to FDA approval following a determination by the agency's Medical Devices Dispute Resolution Panel (MDDRP) that the firm demonstrated a statistically significant treatment effect.